Double-Digit Power Brand Growth Helps Haleon Beat Guidance In 2022
Executive Summary
The growth of its nine power brands helped Haleon outstrip its sales guidance in 2022. While operating profit also improved, the firm was unable to hit its margin guidance, a miss it blamed on adverse transactional foreign currency.
You may also be interested in...
People On The Move: Appointments At Orkla, PAGB, Afepadi
A round-up of the latest appointments in Europe's consumer health industry: Orkla Health names BioGaia's Ducellier as its CEO; PAGB makes changes to its board; and Afepadi names Uriach's Gispert as its president.
Germany's Dermapharm Looks To Future With Arkopharma As 2022 Sales Rise
Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.
Germany's Schwabe Sets Up JV In Brazil With Local Player Herbarium
Schwabe is looking to take a slice of Brazil's growing herbal medicines market by teaming up with local player Herbarium to launch a new joint venture in 2024.